SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is seeing strong community interest driven by its dominance on the Base network and anticipation surrounding a major multi-chain platform merger. Investors are actively discussing the protocol's liquidity-based buyback programs and potential for institutional growth, viewing recent price volatility as an accumulation opportunity ahead of upcoming product rollouts.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as the community debates its long-term potential as a decentralized AI infrastructure play, driven by strategic interest in its agentic AI technology and recent high-profile partnerships. While some investors remain cautious due to broader market volatility and Bitcoin's influence, others are aggressively accumulating, viewing the current price action as a significant discount before a projected shift in the AI narrative.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is trending as investors weigh the company's aggressive shift toward a high-margin, all-digital gaming model against community backlash regarding the potential phasing out of physical discs. Traders are also closely watching the firm's strategic pivot into 'physical AI' and robotics, viewing these as long-term growth catalysts alongside its core entertainment and image sensor divisions.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as investor sentiment shifts due to clinical momentum and strong commercial performance, fueled by speculative buyout interest and an aggressive squeeze on a large short position. The community is actively discussing the stock's transition toward triple-digit valuation targets, with long-term shareholders closely monitoring for potential M&A catalysts.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T shares are currently trending downward as investors express concerns over potential long-term competition from SpaceX's Starlink satellite services in the wireless market. Despite the bearish sentiment, many community members remain bullish on the stock's valuation, highlighting its robust dividend yield and fiber infrastructure as a strong, undervalued buying opportunity.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors debate the impact of its recent research partnership with Honda and technical demonstrations with Ducati, with the community actively speculating on the stock's long-term commercialization path. Conversations are sharply divided between bulls citing the company's solid battery technology and OEM ecosystem, and bears expressing frustration over the lack of revenue and the time horizon for mass production.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd (CRDO) is trending as investors react to its role as a critical connectivity bottleneck play in AI infrastructure, characterized by intense volatility and frequent institutional rebalancing. While community sentiment remains bullish on the company's long-term potential in data center optics and high-speed cabling, many are actively monitoring technical support levels and profit-taking patterns following a significant run-up.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics (DFTX) is trending as investors digest its pivotal Phase 3 clinical trial results, while the broader biotech sector experiences significant momentum. Community discussion remains focused on the company's potential for FDA regulatory pathways, recent upsized capital offerings, and how its drug pipeline competes with established players in the mental health space.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The Russell 2000 ETF (IWM) is seeing significant investor attention due to its recent record-high performance and a broader rotation of capital out of mega-cap tech into small-cap sectors. The community is actively debating the sustainability of this trend, with some traders highlighting the potential risks of a reversal if the current technical structure fails, while others are closely monitoring key support and resistance levels to gauge whether this marks a broader shift in market leadership.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors rally around its v4 launch and a revenue-sharing model that distributes decentralized GPU network earnings to stakers. Community members are actively highlighting the high percentage of supply locked in long-term staking as a key driver of potential supply scarcity and sustained interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SIRI Stock Surges 5% After-Hours On S&P MidCap 400 Inclusion

Equity

The index provider said Sirius XM will take Masimo’s (MASI) slot in the benchmark effective prior to the market open on Thursday, June 11.


Integer Holdings 2026 Outlook: Drivers, Risks, Valuation

ITGR resets its 2026 outlook after customer forecast changes and slower product ramps, with growth and margin recovery tied to adoption timing.

IART vs. MASI: Which Stock Should Value Investors Buy Now?

IART vs. MASI: Which Stock Is the Better Value Option?

MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of +64.79% and -56.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

IART or MASI: Which Is the Better Value Stock Right Now?

Biofrontera Inc. (BFRI) Reports Q1 Loss, Beats Revenue Estimates

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of -127.78% and +6.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates

DarioHealth (DRIO) delivered earnings and revenue surprises of -14.09% and +0.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Masimo Shareholders Approve Acquisition by Danaher

Masimo Corporation (Nasdaq: MASI) (Masimo), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced...

Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones

MASI's SET pulse oximetry shows accurate, consistent readings in hospitalized newborns across all skin tones in the largest real-world study.

Masimo Corporation (NASDAQ:MASI) Short Interest Update

Masimo Corporation (NASDAQ:MASI - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 3,818,925...

Masimo develops and manufactures noninvasive monitoring technologies for healthcare settings. The company designs devices and sensors that measure physiological parameters such as oxygen saturation, pulse rate, respiration rate, and hemoglobin levels through signal processing and sensor-based platforms. Its portfolio includes bedside monitors, wearable devices, hospital automation solutions, and remote patient monitoring systems that integrate with clinical workflows. Masimo also provides hospital connectivity products that support data exchange between medical devices and electronic records systems. The company serves hospitals, emergency medical services, home care providers, and consumers seeking health tracking solutions through clinically validated monitoring technologies.

Masimo Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.43	--	--	N/A
Q1 '26	$1.44	--	--	N/A
Q4 '25	$1.48	-$0.18	-112.17%	MISSED
Q3 '25	$1.20	$1.32	9.89%	BEAT
Q2 '25	$1.22	$1.33	8.77%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

MASIMasimo Corp

Upcoming Earnings: Q2 '26

Historical Earnings

Latest MASI News